Calcium montmorillonite clay reduces AFB1 and FB1 biomarkers in rats exposed to single and co-exposures of aflatoxin and fumonisin

Journal of Applied Toxicology

Volumn 34, Issue 7, 2014, Pages 795-804

  Mitchell, Nicole J ^a   Xue, Kathy S ^b   Lin, Shuhan ^c   Marroquin Cardona, Alicia ^a,e   Brown, Kristal A ^a   Elmore, Sarah E ^a   Tang, Lili ^b   Romoser, Amelia ^a   Gelderblom, Wentzel C A ^c,d   Wang, Jia Sheng ^b   Phillips, Timothy D ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

^e UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

Aflatoxin; Clay adsorption; biomarkers; Fumonisin; HPLC; Toxicity

Indexed keywords

AFLATOXIN B1; ALBUMIN; BIOLOGICAL MARKER; CALCIUM; CALCIUM MONTMORILLONITE; CYTOCHROME; FUMONISIN; MONTMORILLONITE; MYCOTOXIN; UNCLASSIFIED DRUG; AFLATOXIN B1-BOVINE SERUM ALBUMIN; ALUMINUM SILICATE; BENTONITE; CLAY; FUMONISIN B1; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; BIOAVAILABILITY; CHEMICAL BINDING; CLAY; CONTROLLED STUDY; EXPOSURE; GASTROINTESTINAL TRACT; KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SERUM; URINARY EXCRETION; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECTS; FISCHER 344 RAT; KIDNEY; LIVER; METABOLISM; URINE;

AFLATOXIN B1; ALUMINUM SILICATES; ANIMALS; BENTONITE; BIOMARKERS; CALCIUM; FUMONISINS; KIDNEY; LIVER; MALE; RATS; RATS, INBRED F344; SERUM ALBUMIN;

EID: 84901485253     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2942     Document Type: Article

References (66)

1. Abel S, Gelderblom WC. 1998. Oxidative damage and fumonisin B1-induced toxicity in primary rat hepatocytes and rat liver in vivo. Toxicology 131: 121-131.
2. Almeida MI, Almeida NG, Carvalho KL, Goncalves GA, Silva CN, Santos EA, Garcia JC, Vargas EA. 2012. Co-occurrence of aflatoxins B(1), B(2), G(1) and G(2), ochratoxin A, zearalenone, deoxynivalenol, and citreoviridin in rice in Brazil. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 29: 694-703.
3. Azziz-Baumgartner E, Lindblade K, Gieseker K, Rogers HS, Kieszak S, Njapau H, Schleicher R, McCoy LF, Misore A, DeCock K, Rubin C, Slutsker L. 2005. Case-control study of an acute aflatoxicosis outbreak, Kenya, 2004. Environ. Health Perspect. 113: 1779-1783.
4. Beaver RW, Wilson DM, James MA, Haydon KD, Colvin BM, Sangster LT, Pikul AH, Groopman JD. 1990. Distribution of aflatoxins in tissues of growing pigs fed an aflatoxin-contaminated diet amended with a high affinity aluminosilicate sorbent. Vet. Hum. Toxicol. 32: 16-18.
5. Bingham AK, Huebner HJ, Phillips TD, Bauer JE. 2004. Identification and reduction of urinary aflatoxin metabolites in dogs. Food Chem. Toxicol. 42: 1851-1858.
6. Bouhet S, Oswald IP. 2007. The intestine as a possible target for fumonisin toxicity. Mol. Nutr. Food Res. 51: 925-931.
7. Brown KA, Mays T, Romoser A, Marroquin-Cardona A, Mitchell NJ, Elmore SE, Phillips TD. 2012. Modified hydra bioassay to evaluate the toxicity of multiple mycotoxins and predict the detoxification efficacy of a clay-based sorbent. J. Appl. Toxicol. [Epub ahead of print]. 10.1002/jat.2824.
8. Cai Q, Tang L, Wang JS. 2007. Validation of fumonisin biomarkers in F344 rats. Toxicol. Appl. Pharmacol. 225: 28-39.
9. Carlson DB, Williams DE, Spitsbergen JM, Ross PF, Bacon CW, Meredith FI, Riley RT. 2001. Fumonisin B1 promotes aflatoxin B1 and N-methyl-N'-nitro-nitrosoguanidine-initiated liver tumors in rainbow trout. Toxicol. Appl. Pharmacol. 172: 29-36.
10. Carpenter DO, Arcaro KF, Bush B, Niemi WD, Pang S, Vakharia DD. 1998. Human health and chemical mixtures: an overview. Environ. Health Perspect. 106(Suppl 6): 1263-1270.
11. CAST. 2003. Mycotoxins: risks in plant, animals, and human systems. (Task force report). Ames, Iowa: Council of Agriculture, Science, and Technology. 13-85.
12. Chu F, Li G. 1994. Simultaneous occurrence of fumonisin B1 and other mycotoxins in moldy corn collected from the People's Republic of China in regions with high incidences of oesophageal cancer. Appl. Environ. Microbiol. 60: 847-852.
13. Colvin BM, Sangster LT, Haydon KD, Beaver RW, Wilson DM. 1989. Effect of a high affinity aluminosilicate sorbent on prevention of aflatoxicosis in growing pigs. Veterinary and human toxicology 31: 46-48.
14. Coulumbe Jr RA. 1994. Nonhepatic disposition and effects of aflatoxin B1. In Toxicology of Aflatoxins: Human Health, Veterinary, and Agricultural Significance, Eaton DL, Groopman JD (eds). Academic Press, Inc.: San Diego; 89-101.
15. Dilkin P, Zorzete P, Mallmann CA, Gomes JD, Utiyama CE, Oetting LL, Correa B. 2003. Toxicological effects of chronic low doses of aflatoxin B(1) and fumonisin B(1)-containing Fusarium moniliforme culture material in weaned piglets. Food Chem. Toxicol. 41: 1345-1353.
16. Domijan AM, Abramov AY. 2011. Fumonisin B1 inhibits mitochondrial respiration and deregulates calcium homeostasis-implication to mechanism of cell toxicity. Int. J. Biochem. Cell Biol. 43: 897-904.
17. Edrington TS, Sarr AB, Kubena LF, Harvey RB, Phillips TD. 1996. Hydrated sodium calcium aluminosilicate (HSCAS), acidic HSCAS, and activated charcoal reduce urinary excretion of aflatoxin M1 in turkey poults. Lack of effect by activated charcoal on aflatoxicosis. Toxicol. Lett. 89: 115-122.
18. Gan LS, Skipper PL, Peng XC, Groopman JD, Chen JS, Wogan GN, Tannenbaum SR. 1988. Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1. Carcinogenesis 9: 1323-1325.
19. Gelderblom WC, Cawood ME, Snyman SD, Marasas WF. 1994. Fumonisin B1 dosimetry in relation to cancer initiation in rat liver. Carcinogenesis 15: 209-214.
20. Gelderblom WC, Marasas WF, Lebepe-Mazur S, Swanevelder S, Vessey CJ, Hall PL. 2002. Interaction of fumonisin B(1) and aflatoxin B(1) in a short-term carcinogenesis model in rat liver. Toxicology 171: 161-173.
21. Gelderblom WC, Jaskiewicz K, Marasas WF, Thiel PG, Horak RM, Vleggaar R, Kriek NP. 1988. Fumonisins--novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Appl. Environ. Microbiol. 54: 1806-1811.
22. Gelderblom WC, Abel S, Smuts CM, Marnewick J, Marasas WF, Lemmer ER, Ramljak D. 2001. Fumonisin-induced hepatocarcinogenesis: mechanisms related to cancer initiation and promotion. Environ. Health Perspect. 109(Suppl 2): 291-300.
23. Gong Y, Hounsa A, Egal S, Turner PC, Sutcliffe AE, Hall AJ, Cardwell K, Wild CP. 2004. Postweaning exposure to aflatoxin results in impaired child growth a longitudinal study in Benin, West Africa. Environ. Health Perspect. 112: 1334-1338.
24. Gong YY, Cardwell K, Hounsa A, Egal S, Turner PC, Hall AJ, Wild CP. 2002. Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional study. BMJ 325: 20-21.
25. Grant PG, Phillips TD. 1998. Isothermal Adsorption of Aflatoxin B(1) on HSCAS Clay. J. Agric. Food Chem. 46: 599-605.
26. Grenier B, Appelgate TJ. 2013. Modulation of intestinal functions following mycotoxin ingestion: meta-analysis of published experiments in animals. Toxins 5: 396-430.
27. Grenier B, Loureiro-Bracarense A-P, Lucioli J, Pacheco GD, Cossalter A-M, Moll W-D, Schatzmayr G, Oswald I. 2011. Individual and combined effects of subclinical doses of deoxynivalenol and fumonisins in piglets. Mol. Nutr. Food Res. 55: 761-771.
28. Groopman JD, Wogan GN, Roebuck BD, Kensler TW. 1994. Molecular biomarkers for aflatoxins and their application to human cancer prevention. Cancer Res. 54: 1907s-1911s.
29. Groopman JD, Hasler JA, Trudel LJ, Pikul A, Donahue PR, Wogan GN. 1992. Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunonity/high performance liquid chromatography. Cancer Res. 52: 267-274.
30. IARC. 1993. Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC Mongr. Eval. Carcinog. Risks Hum. 56: 207-271.
31. IARC. 2002. Some traditional herbal medicines, some mycotoxins, napthalene and styrene. IARC Monogr. Eval. Carcinog. Risks Hum. 82: 171-274.
32. Kimanya ME, De Meulenaer B, Roberfroid D, Lachat C, Kolsteren P. 2010. Fumonisin exposure through maize in complementary foods is inversely associated with linear growth of infants in Tanzania. Mol. Nutr. Food Res. 54: 1659-1667.
33. Kimanya ME, DeMeulenaer B, Tiisekwa B, Ndomondo-Sigonda M, Devlieghere F, Camp JV, Kolsteren P. 2008. Co-occurrence of fumonisins with aflatoxins in home-stored maize for human consumption in rural villages of Tanzania. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 25: 1353-1364.
34. Kpodo K, Thrane U, Hald B. 2000. Fusaria and fumonisins in maize from Ghana and their co-occurrence with aflatoxins. Int. J. Food Microbiol. 61: 147-157.
35. Lewis L, Onsongo M, Njapau H, Schurz-Rogers H, Luber G, Kieszak S, Nyamongo J, Backer L, Dahiye AM, Misore A, DeCock K, Rubin C. 2005. Aflatoxin contamination of commercial maize products during an outbreak of acute aflatoxicosis in eastern and central Kenya. Environ. Health Perspect. 113: 1763-1767.
36. Marasas W, Riley R, Hendricks K, Stevens V, Sadler T, Gelineau-van Waes J, Missmer S, Cabrera J, Torres O, Gelderblom W, Allegood J, Martínez C, Maddox J, Miller J, Starr L, Sullards M, Roman A, Voss K, Wang E, Merrill Jr. A. 2004. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo a potential risk factor for human neural tube defects among populations consuming fumonisin- contaminated maize. J. Nutr. 134: 711-716.
37. Marroquin-Cardona A, Deng Y, Garcia-Mazcorro J, Johnson NM, Mitchell N, Tang L, Robinson A, 2nd, Taylor J, Wang JS, Phillips TD. 2011. Characterization and Safety of Uniform Particle Size NovaSil Clay as a Potential Aflatoxin Enterosorbent. Appl. Clay Sci. 54: 248-257.
38. Martinez-Larranaga M, Anadon A, Diaz M, Fernandez-Cruz M, Martinez M, Frejo M, Martinez M, Fernandez R, Anton R, Morales M, Tafur M. 1999. Toxicokinetics and oral bioavailability of fumonisin B1. Vet. Hum. Toxicol. 41: 357-362.
39. Martinez-Larranaga MR, Anadon A, Diaz MJ, Fernandez R, Sevil B, Fernandez-Cruz ML, Fernandez MC, Martinez MA, Anton R. 1996. Induction of cytochrome P4501A1 and P4504A1 activities and peroxisomal proliferation by fumonisin B1. Toxicol. Appl. Pharmacol. 141: 185-194.
40. Massey TE, Stewart RK, Daniels JM, Liu L. 1995. Biochemical and molecular aspects of mammalian susceptibility to aflatoxin B1 carcinogenicity. Proc. Soc. Exp. Biol. Med. 208: 213-227.
41. McKean C, Tang L, Tang M, Billam M, Wang Z, Theodorakis CW, Kendall RJ, Wang JS. 2006. Comparative acute and combinative toxicity of aflatoxin B1 and fumonisin B1 in animals and human cells. Food Chem. Toxicol. 44: 868-876.
42. Phillips TD, Sarr AB, Grant PG. 1995. Selective chemisorption and detoxification of aflatoxins by phyllosilicate clay. Nat. Toxins 3: 204-213.
43. Phillips TD, Lemke SL, Grant PG. 2002. Characterization of clay-based enterosorbents for the prevention of aflatoxicosis. Adv. Exp. Med. Biol. 504: 157-171.
44. Phillips TD, Kubena LF, Harvey RB, Taylor DR, Heidelbaugh ND. 1988. Hydrated sodium calcium aluminosilicate a highnity sorbent for aflatoxin. Poult. sci. 67: 243-247.
45. Phillips TD, Afriyie-Gyawu E, Williams J, Huebner H, Ankrah NA, Ofori-Adjei D, Jolly P, Johnson N, Taylor J, Marroquin-Cardona A, Xu L, Tang L, Wang JS. 2008. Reducing human exposure to aflatoxin through the use of clay a review. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 25: 134-145.
46. Pimpukdee K, Kubena LF, Bailey CA, Huebner HJ, Afriyie-Gyawu E, Phillips TD. 2004. Aflatoxin-induced toxicity and depletion of hepatic vitamin A in young broiler chicks: Protection of chicks in the presence of low levels of NovaSil PLUS in the diet. Poultry Sci. 83: 737-744.
47. Qian G, Tang L, Liu W, Wang JS. 2010. Development of a non-antibody method for rapid detection of serum aflatoxin B1-lysine adduct. The Toxicologist 114: 248.
48. Qian G, Tang L, Wang F, Guo X, Massey ME, Williams JH, Phillips TD, Wang JS. 2013. Physiologically based toxicokinetics of serum aflatoxin B1-lysine adduct in F344 rats. Toxicology 303: 147-151.
49. Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN, Groopman JD. 1994. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol. Biomarkers Prev. 3: 3-10.
50. Riley RT, Enongene E, Voss KA, Norred WP, Meredith FI, Sharma RP, Spitsbergen J, Williams DE, Carlson DB, Merrill AH, Jr. 2001. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ. Health Perspect. 109(Suppl 2): 301-308.
51. Robinson A, Johnson NM, Strey A, Taylor JF, Marroquin-Cardona A, Mitchell NJ, Afriyie-Gyawu E, Ankrah NA, Williams JH, Wang JS, Jolly PE, Nachman RJ, Phillips TD. 2012. Calcium montmorillonite clay reduces urinary biomarkers of fumonisin B(1) exposure in rats and humans. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 29: 809-818.
52. Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, Groopman JD, Gao YT, Henderson BE. 1992. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339: 943-946.
53. Rumora L, Domijan AM, Grubisic TZ, Peraica M. 2007. Mycotoxin fumonisin B1 alters cellular redox balance and signaling pathways in rat liver and kidney. Toxicology 242: 31-38.
54. Sarr AB, Mayura K, Kubena LF, Harvey RB, Phillips TD. 1995. Effects of phyllosilicate clay on the metabolic profile of aflatoxin B1 in Fischer-344 rats. Toxicol. Lett. 75: 145-151.
55. Scholl P, Musser SM, Kensler TW, Groopman JD. 1996. Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz. Carcinogenesis 17: 1385-1388.
56. Shephard GS, Van Der Westhuizen L, Sewram V. 2007. Biomarkers of exposure to fumonisin mycotoxins a review. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 24: 1196-1201.
57. Sun G, Wang S, Hu X, Su J, Zhang Y, Xie Y, Zhang H, Tang L, Wang JS. 2011. Co-contamination of aflatoxin B1 and fumonisin B1 in food and human dietary exposure in three areas of China. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 28: 461-470.
58. Voss K, Howard P, Riley R, Sharma R, Bucci T, Lorentzen R. 2002. Carcinogenicity and mechanism of action of fumonisin B1 a mycotoxin produced by Fusarium moniliforme (=F. verticillioides). Cancer Detect. Prev. 26: 1-9.
59. Wang JS, Shen X, He X, Zhu YR, Zhang BC, Wang JB, Qian GS, Kuang SY, Zarba A, Egner PA, Jacobson LP, Munoz A, Helzlsouer KJ, Groopman JD, Kensler TW. 1999. Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. J. National Cancer Inst. 91: 347-354.
60. Wang LY, Hatch M, Chen CJ, Levin B, You SL, Lu SN, Wu MH, Wu WP, Wang LW, Wang Q, Huang GT, Yang PM, Lee HS, Santella RM. 1996. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int. J. Cancer 67: 620-625.
61. Wang P, Afriyie-Gyawu E, Tang Y, Johnson NM, Xu L, Tang L, Huebner HJ, Ankrah NA, Ofori-Adjei D, Ellis W, Jolly PE, Williams JH, Wang JS, Phillips TD. 2008. NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in biomarkers of aflatoxin exposure in blood and urine. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 25: 622-634.
62. Wild CP, Gong YY. 2010. Mycotoxins and human disease a largely ignored global health issue. Carcinogenesis 31: 71-82.
63. Williams JH, Phillips TD, Jolly PE, Stiles JK, Jolly CM, Aggarwal D. 2004. Human aflatoxicosis in developing countries a review of toxicology, exposure, potential health consequences, and interventions. The Am. J. Clin. Nutr. 80: 1106-1122.
64. Wogan GN. 1992. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res. 52: 2114s-2118s.
65. Xu L, Cai Q, Tang L, Wang S, Hu X, Su J, Sun G, Wang JS. 2010. Evaluation of fumonisin biomarkers in a cross-sectional study with two high-risk populations in China. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 27: 1161-1169.
66. Yu MW, Lien JP, Chiu YH, Santella RM, Liaw YF, Chen CJ. 1997. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. J. Hepatol. 27: 320-330.